Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

BACKGROUND: Nephropathy is an important feature of classical Fabry disease, which results in alpha-galactosidase A deficiency and cellular globotriaosylceramide accumulation. We report the safety and efficacy of antiproteinuric therapy with ACE inhibitors or angiotensin II receptor blockers (ARBs) i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Med Genet
Autori principali: Warnock, David G, Thomas, Christie P, Vujkovac, Bojan, Campbell, Ruth C, Charrow, Joel, Laney, Dawn A, Jackson, Leslie L, Wilcox, William R, Wanner, Christoph
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2015
Soggetti:
Phenotypes
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717450/
https://ncbi.nlm.nih.gov/pubmed/26490103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2015-103471
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi